ArticleThe Eurasian journal of medicine2025
Association Between Mean Platelet Volume and Other Inflammatory Markers in Patients with Influenza A (H1N1).
Article in The Eurasian journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluenza is a viral infection affecting all age groups, with high transmissibility and the potential to cause epidemics and pandemics. Accurate and early prognosis prediction is essential for effective disease management and outbreak control. The objective of the present research was to assess the significance of mean platelet volume (MPV) and its relationship with inflammatory markers, particularly C-reactive protein (CRP), in predicting the prognosis of Influenza A (H1N1) infection.
methodsA retrospective analysis was conducted on 133 hospitalized patients who presented with respira tory symptoms and tested positive for H1N1 via nasopharyngeal swab. Data on MPV and CRP levels were collected at admission. The presence of comorbidities and clinical outcomes, including mortality, were also recorded. The relationship between MPV, CRP, and patient outcomes was statistically evaluated.
resultsComorbid conditions were found in 66.2% of the patients. Among the 31 patients who died (23.3%), 77.4% had comorbidities. Mortality was significantly higher in those with comorbidities (27.3%) than those without (15.5%). Compared with the healthy control group, patients exhibited a markedly lower MPV and higher CRP levels (both P < .005). Intensive care unit (ICU) patients had higher CRP levels than non-ICU patients (P < .005), but MPV did not differ significantly (P = .638). Higher CRP was associated with mortality (P < .005), whereas MPV showed no significant association (P = .086).
conclusionH1N1 infection has the potential to cause severe and fatal outcomes, particularly in elderly patients with comorbidities. Elevated CRP at admission may serve as a valuable prognostic marker. Although MPV may contribute diagnostically, its prognostic utility appears limited compared to CRP. Cite this article as: Tüzün Z, Saler T, Tüzün K, Çelik U, Avci BŞ. Association between mean platelet volume and other inflammatory markers in patients with influenza A (H1N1). Eurasian J Med. 2025, 57(4), 0972, doi:10.5152/eurasianjmed.2025.25972.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.